Sherbrooke Park Advisers LLC Amneal Pharmaceuticals, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 12,274 shares of AMRX stock, worth $96,105. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,274
Previous 66,567
81.56%
Holding current value
$96,105
Previous $554 Million
82.45%
% of portfolio
0.03%
Previous 0.13%
Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$116 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$96.5 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$88.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$84 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$70.3 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.19B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...